|
Volumn 9, Issue 3, 1995, Pages 229-234
|
Malignant gliomas in older adults with poor prognostic signs. Getting nowhere, and taking a long-time to do it
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
BLEOMYCIN SULFATE;
CARMUSTINE;
DIAZIQUONE;
LOMUSTINE;
MERCAPTOPURINE;
MITOMYCIN C;
PROCARBAZINE;
SEMUSTINE;
VINCRISTINE;
VINCRISTINE SULFATE;
ADULT;
AGED;
BRAIN TUMOR;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CLINICAL TRIAL;
GLIOMA;
HUMAN;
REVIEW;
AGE FACTORS;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARMUSTINE;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS, PHASE II;
COMBINED MODALITY THERAPY;
FEMALE;
GLIOMA;
HUMAN;
MALE;
MIDDLE AGE;
PROGNOSIS;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS;
SUPRATENTORIAL NEOPLASMS;
SURVIVAL RATE;
UNITED STATES;
|
EID: 0028934377
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (40)
|
References (0)
|